08-04-2011

Roche Diagnosticsis cooperating with the Spanish Vall d’Hebron Institute of Research (VHIR), the Networking Biomedical Research Centre in Liver and Digestive Diseases (CIBEREHD), and the software producer Advanced Biological Laboratories Therapy Edge Spain (ABL) in a study designed to resolve ...

more

04-04-2011

Roche Diagnostics announced that effective from April 1, Robert Yates has been appointed as new Head of Roche Applied Science. He succeeds Manfred Baier, who will be retiring from Roche at the end of 2011. Robert Yates subsequently held increasing leadership positions in R&D, engineering and ...

more

Collaboration to enable scientists to capture known and unknown functional mutations associated with core set of pharmacokinetic and pharmacology genes

09-03-2011

RainDance Technologies, Inc., and 454 Life Sciences, a Roche Company, announced collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for simple and cost-effective investigation of drug absorption, distribution, metabolism, and ...

more

Broad Claims Granted for Cytotoxicity Profiling and Chemical Compound Testing

18-02-2011

ACEA Biosciences, Inc. reported the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products. Testing and profiling of these candidate compounds by means of ACEA's real-time, label-free microelectronic ...

more

07-07-2010

Effectively July 1, Roche Applied Science Industrial Business was relaunched under the name Roche Custom Biotech. The switch will be accompanied by a complete makeover of the Industrial Business appearance. Besides the new name and slogan – “Expertise you can trust” - there will also be a new ...

more

02-07-2010

Roche and IBM announced an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM’s recently published “DNA Transistor” technology, the collaboration will take advantage of IBM’s leadership in ...

more

29-03-2010

Roche NimbleGen announced that Frank Pitzer has been appointed as CEO. Dr. Pitzer’s extensive background and experience of over eight years at Roche will be instrumental in guiding the company through its next stage of growth. With his successful track record in several key management ...

more

15-03-2010

Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow. These assets consist of key instrumentation in the Roche NimbleGen microarray workflow. Also included in this purchase are array accessories covering all ...

more

16-02-2010

Roche NimbleGen announced that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. CapitalBio has been certified to process customer samples for NimbleGen Gene Expression, Comparative Genomic Hybridization/Copy ...

more

14-01-2010

KINAXO Biotechnologies GmbH announced that it has entered into a second collaboration with Roche Diagnostics GmbH. Under the agreement KINAXO will apply its phosphoproteomics technology PhosphoScout® to support targeted treatment approaches currently under development at Roche. Financial ...

more